Invention Grant
- Patent Title: GLS1 inhibitors for treating disease
-
Application No.: US16918897Application Date: 2020-07-01
-
Publication No.: US11713313B2Publication Date: 2023-08-01
- Inventor: Richard Thomas Lewis , Philip Jones , Alessia Petrocchi , Naphtali Reyna , Matthew Hamilton , Michael J. Soth , Timothy Heffernan , Michelle Han , Jason P. Burke
- Applicant: Board of Regents, The University of Texas System
- Applicant Address: US TX Austin
- Assignee: Board of Regents, The University of Texas System
- Current Assignee: Board of Regents, The University of Texas System
- Current Assignee Address: US TX Austin
- Agent Cynthia Hathaway; Lauren L. Stevens; Erik M. Larsen
- The original application number of the division: US15199100 2016.06.30
- Main IPC: C07D417/14
- IPC: C07D417/14 ; A61K31/501 ; A61K45/06 ; C07D403/14 ; C07D401/14 ; A61K31/454 ; A61K31/4545 ; A61K31/4439
Abstract:
Disclosed herein are compounds and compositions useful in the treatment of GLS1 mediated diseases, such as cancer, having the structure of Formula I:
Methods of inhibition GLS1 activity in a human or animal subject are also provided.
Methods of inhibition GLS1 activity in a human or animal subject are also provided.
Public/Granted literature
- US20210122744A1 GLS1 INHIBITORS FOR TREATING DISEASE Public/Granted day:2021-04-29
Information query
